Top Markets
Coin of the day
Evogene Ltd. Evogene Ltd.

Evogene Ltd.

EVGN
Classement en actions #41006
Evogene Ltd. is a computational biology firm specializing in the identification... Evogene Ltd. is a computational biology firm specializing in the identification and advancement of products across human health and agricultural sectors. Its proprietary Computational Predictive Biology (CPB) platform leverages deep biological insights, big data, and artificial intelligence to precisely uncover and guide the creation of life science solutions, including novel microbes, small molecules, and genetic components. The company operates through distinct divisions: Agriculture, Human Health, and Industrial Applications. The Agriculture division concentrates on improving crop performance through the development of advanced seed traits, agricultural chemicals, and biological products for crops like corn, soybean, wheat, rice, and cotton. The Human Health division focuses on pioneering microbiome-based treatments for conditions such as immuno-oncology, gastrointestinal ailments, and antibiotic-resistant infections, and also offers medical cannabis products. The Industrial Applications segment is dedicated to developing improved castor bean varieties for various industrial feedstock requirements. Evogene has a global footprint, conducting business in the United States, Israel, Brazil, and other international markets. It maintains significant partnerships, including agricultural collaborations with BASF SE, Corteva, and Bayer, and a medical cannabis development agreement with Cannbit Ltd. through its subsidiary, Canonic Ltd. Established in 1999, Evogene Ltd. is headquartered in Rehovot, Israel.
Prix de l'action
$0.60231699
Capitalisation boursière
$51.90K
Changement (1 jour)
0.16%
Changement (1 an)
-52.38%
Pays
IL
Échange Evogene Ltd. (EVGN)

Catégorie

Le prix EVGN avec la capitalisation boursière de B
Evogene Ltd. Evogene Ltd.
EVGN
$0.60231699
Capitalisation boursière de Evogene Ltd.(EVGN)
Capitalisation boursière: $51.90K
En August 2026, Evogene Ltd. a une capitalisation boursière de $51.90K. Cela fait de Evogene Ltd. la 41006th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Evogene Ltd. du 2007 au 2026
EVGN par rapport au top 5 des plus populaires stocks
Prix pour EVGN L’actif B La capitalisation boursière de B Résultats
Evogene Ltd. Evogene Ltd.
$62,475,159 $51.90K
$5.383T +10,372,471,519.32%
Evogene Ltd. Evogene Ltd.
$51,334,500 $51.90K
$4.423T +8,522,837,741.84%
Evogene Ltd. Evogene Ltd.
$48,282,070 $51.90K
$4.160T +8,016,056,386.38%
Evogene Ltd. Evogene Ltd.
$42,513,704 $51.90K
$3.663T +7,058,360,333.96%
Evogene Ltd. Evogene Ltd.
$33,553,393 $51.90K
$2.891T +5,570,719,976.95%